As of 2025-04-22, the EV/EBITDA ratio of Pulmonx Corp (LUNG) is -2.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LUNG's latest enterprise value is 148.20 mil USD. LUNG's TTM EBITDA according to its financial statements is -54.35 mil USD. Dividing these 2 quantities gives us the above LUNG EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 13.9x | 13.8x |
| Forward P/E multiples | 10.3x - 12.7x | 11.5x |
| Fair Price | (17.66) - (16.31) | (16.25) |
| Upside | -490.8% - -460.9% | -459.4% |
| Date | EV/EBITDA |
| 2025-04-17 | -2.73 |
| 2025-04-16 | -2.93 |
| 2025-04-15 | -3.02 |
| 2025-04-14 | -3.39 |
| 2025-04-11 | -3.27 |
| 2025-04-10 | -3.24 |
| 2025-04-09 | -3.40 |
| 2025-04-08 | -3.62 |
| 2025-04-07 | -4.27 |
| 2025-04-04 | -4.39 |
| 2025-04-03 | -4.39 |
| 2025-04-02 | -4.43 |
| 2025-04-01 | -4.47 |
| 2025-03-31 | -4.36 |
| 2025-03-28 | -4.43 |
| 2025-03-27 | -4.41 |
| 2025-03-26 | -4.37 |
| 2025-03-25 | -4.47 |
| 2025-03-24 | -4.84 |
| 2025-03-21 | -5.13 |
| 2025-03-20 | -5.08 |
| 2025-03-19 | -5.13 |
| 2025-03-18 | -5.28 |
| 2025-03-17 | -5.15 |
| 2025-03-14 | -4.95 |
| 2025-03-13 | -4.60 |
| 2025-03-12 | -4.80 |
| 2025-03-11 | -4.79 |
| 2025-03-10 | -4.72 |
| 2025-03-07 | -4.92 |
| 2025-03-06 | -4.89 |
| 2025-03-05 | -5.44 |
| 2025-03-04 | -5.80 |
| 2025-03-03 | -5.52 |
| 2025-02-28 | -5.76 |
| 2025-02-27 | -5.76 |
| 2025-02-26 | -6.21 |
| 2025-02-25 | -5.81 |
| 2025-02-24 | -5.98 |
| 2025-02-21 | -6.01 |
| 2025-02-20 | -5.88 |
| 2025-02-19 | -4.30 |
| 2025-02-18 | -4.56 |
| 2025-02-14 | -4.54 |
| 2025-02-13 | -4.84 |
| 2025-02-12 | -4.57 |
| 2025-02-11 | -4.44 |
| 2025-02-10 | -4.33 |
| 2025-02-07 | -4.29 |
| 2025-02-06 | -4.14 |